Dosimetric advantages of IMRT simultaneous integrated boost for high-risk prostate cancer.
Int. J. Radiat. Oncol. Biol. Phys. 2005 Mar 15; 61 (4): 1251-7.
Int. J. Radiat. Oncol. Biol. Phys. 2003 Nov 1; 57 (3): 875-90.
Influence of MRI on target volume delineation and IMRT planning in nasopharyngeal carcinoma.
Int. J. Radiat. Oncol. Biol. Phys. 2003 Oct 1; 57 (2): 481-8.